Cargando…

Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu

BACKGROUND: Vanuatu was formerly highly endemic for lymphatic filariasis (LF), caused by Wuchereria bancrofti and transmitted by Anopheles mosquitoes. After a baseline survey showing 4.8% antigen prevalence in 1998, the country conducted nationwide (in one implementation unit) annual mass drug admin...

Descripción completa

Detalles Bibliográficos
Autores principales: Taleo, Fasihah, Taleo, George, Graves, Patricia M., Wood, Peter, Kim, Sung Hye, Ozaki, Masayo, Joseph, Hayley, Chu, Brian, Pavluck, Alex, Yajima, Aya, Melrose, Wayne, Ichimori, Kazuyo, Capuano, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472907/
https://www.ncbi.nlm.nih.gov/pubmed/28630586
http://dx.doi.org/10.1186/s41182-017-0057-6
_version_ 1783244203694751744
author Taleo, Fasihah
Taleo, George
Graves, Patricia M.
Wood, Peter
Kim, Sung Hye
Ozaki, Masayo
Joseph, Hayley
Chu, Brian
Pavluck, Alex
Yajima, Aya
Melrose, Wayne
Ichimori, Kazuyo
Capuano, Corinne
author_facet Taleo, Fasihah
Taleo, George
Graves, Patricia M.
Wood, Peter
Kim, Sung Hye
Ozaki, Masayo
Joseph, Hayley
Chu, Brian
Pavluck, Alex
Yajima, Aya
Melrose, Wayne
Ichimori, Kazuyo
Capuano, Corinne
author_sort Taleo, Fasihah
collection PubMed
description BACKGROUND: Vanuatu was formerly highly endemic for lymphatic filariasis (LF), caused by Wuchereria bancrofti and transmitted by Anopheles mosquitoes. After a baseline survey showing 4.8% antigen prevalence in 1998, the country conducted nationwide (in one implementation unit) annual mass drug administration (MDA) with albendazole and diethylcarbamazine citrate from 2000 to 2004 and achieved prevalence of 0.2% by 2006 in a representative nationwide cluster survey among all age groups. METHODS: Post MDA surveillance was conducted from 2006 to 2012. After MDA, the country was divided for surveillance into three evaluation units (EUs) formed by grouping provinces according to baseline prevalence: EU1: Torba, Sanma and Malampa; EU2: Penama; EU3: Shefa and Tafea. The study compiled all past data and information on surveys in Vanuatu from the country programme. This paper reviews the surveillance activities done after stopping MDA to validate the interruption of transmission and elimination of LF as a public health problem. RESULTS: Post-MDA surveillance consisting of at least three transmission assessment surveys (TAS) in each of the three EUs was conducted between 2006 and 2012. Sentinel and spot check surveys identified a few villages with persistent high prevalence; all antigen positive cases in these sites were treated and additional targeted MDA conducted for 3 years in 13 villages in one area of concern. All three EUs passed all TAS in 2007, 2010 and 2012 respectively, with no positives found except in EU2 (Penama province) in 2012 when 2 children tested positive for circulating filariasis antigen. Assessment of the burden of chronic filariasis morbidity found 95 cases in 2003 and 32 remaining cases in 2007, all aged over 60 years. CONCLUSIONS: Vanuatu has achieved validation of elimination of LF as a public health problem. Post-validation surveillance is still recommended especially in formerly highly endemic areas.
format Online
Article
Text
id pubmed-5472907
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54729072017-06-19 Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu Taleo, Fasihah Taleo, George Graves, Patricia M. Wood, Peter Kim, Sung Hye Ozaki, Masayo Joseph, Hayley Chu, Brian Pavluck, Alex Yajima, Aya Melrose, Wayne Ichimori, Kazuyo Capuano, Corinne Trop Med Health Research BACKGROUND: Vanuatu was formerly highly endemic for lymphatic filariasis (LF), caused by Wuchereria bancrofti and transmitted by Anopheles mosquitoes. After a baseline survey showing 4.8% antigen prevalence in 1998, the country conducted nationwide (in one implementation unit) annual mass drug administration (MDA) with albendazole and diethylcarbamazine citrate from 2000 to 2004 and achieved prevalence of 0.2% by 2006 in a representative nationwide cluster survey among all age groups. METHODS: Post MDA surveillance was conducted from 2006 to 2012. After MDA, the country was divided for surveillance into three evaluation units (EUs) formed by grouping provinces according to baseline prevalence: EU1: Torba, Sanma and Malampa; EU2: Penama; EU3: Shefa and Tafea. The study compiled all past data and information on surveys in Vanuatu from the country programme. This paper reviews the surveillance activities done after stopping MDA to validate the interruption of transmission and elimination of LF as a public health problem. RESULTS: Post-MDA surveillance consisting of at least three transmission assessment surveys (TAS) in each of the three EUs was conducted between 2006 and 2012. Sentinel and spot check surveys identified a few villages with persistent high prevalence; all antigen positive cases in these sites were treated and additional targeted MDA conducted for 3 years in 13 villages in one area of concern. All three EUs passed all TAS in 2007, 2010 and 2012 respectively, with no positives found except in EU2 (Penama province) in 2012 when 2 children tested positive for circulating filariasis antigen. Assessment of the burden of chronic filariasis morbidity found 95 cases in 2003 and 32 remaining cases in 2007, all aged over 60 years. CONCLUSIONS: Vanuatu has achieved validation of elimination of LF as a public health problem. Post-validation surveillance is still recommended especially in formerly highly endemic areas. BioMed Central 2017-06-16 /pmc/articles/PMC5472907/ /pubmed/28630586 http://dx.doi.org/10.1186/s41182-017-0057-6 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Taleo, Fasihah
Taleo, George
Graves, Patricia M.
Wood, Peter
Kim, Sung Hye
Ozaki, Masayo
Joseph, Hayley
Chu, Brian
Pavluck, Alex
Yajima, Aya
Melrose, Wayne
Ichimori, Kazuyo
Capuano, Corinne
Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
title Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
title_full Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
title_fullStr Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
title_full_unstemmed Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
title_short Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu
title_sort surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in vanuatu
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472907/
https://www.ncbi.nlm.nih.gov/pubmed/28630586
http://dx.doi.org/10.1186/s41182-017-0057-6
work_keys_str_mv AT taleofasihah surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT taleogeorge surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT gravespatriciam surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT woodpeter surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT kimsunghye surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT ozakimasayo surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT josephhayley surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT chubrian surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT pavluckalex surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT yajimaaya surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT melrosewayne surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT ichimorikazuyo surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu
AT capuanocorinne surveillanceeffortsaftermassdrugadministrationtovalidateeliminationoflymphaticfilariasisasapublichealthprobleminvanuatu